Price range: $250.00 through $800.00
MOTS-c is a mitochondria-derived peptide studied for its role in metabolic regulation and cellular energy signaling. Encoded within mitochondrial DNA, MOTS-c is evaluated in research environments for its influence on AMPK activation, glucose metabolism, and adaptive stress-response pathways.
As a mitochondrial signaling peptide, MOTS-c is of particular interest in metabolic efficiency, insulin-sensitivity modeling, and endurance-based research frameworks.
Research Name: MOTS-c
Category: Mitochondria-derived metabolic peptide
Primary Research Focus: AMPK activation, glucose metabolism, energy homeostasis
Format: Lyophilized powder
Upon reconstitution with an appropriate volume of bacteriostatic water, final concentration will vary depending on total diluent added. Researchers calculate concentration using the standard formula:
Total mg in vial ÷ Total mL added = mg per mL
For U-100 insulin syringes:
1 mL = 100 units
Units required are determined by dividing the desired mg amount by the final mg/mL concentration.
MOTS-c is studied for its potential influence on:
Metabolic Regulation
AMPK pathway activation
Glucose uptake modeling
Insulin-sensitivity frameworks
Mitochondrial & Cellular Energy Signaling
ATP production efficiency
Adaptive stress-response pathways
Cellular fuel utilization dynamics
Body-Composition & Endurance Research
Fat oxidation modeling
Skeletal muscle metabolic signaling
Exercise-response adaptation studies
Its mitochondrial origin differentiates MOTS-c from receptor-based incretin or endocrine peptides, positioning it within advanced bioenergetic research models.
Within structured research environments, investigators may observe:
Dose-dependent variables
Energy-expenditure shifts
Glucose marker fluctuations
Appetite variability
Metabolic observations
Body-composition trend changes
Endurance-capacity variation
Lipid metabolism marker shifts
Less frequent observations
Mild headache
Injection-site irritation
Temporary fatigue during adaptation
Monitoring commonly focuses on metabolic biomarkers and insulin-related parameters.
Administration Frequency: Varies by study design (often multiple times weekly)
Common Study Duration: 4–12 weeks
Titration Strategy: Incremental adjustments to evaluate metabolic response
Researchers may exercise caution when combining MOTS-c with other AMPK-activating or metabolic-modulating compounds to prevent overlapping pathway effects.
Store lyophilized vial in a cool, dry environment.
Refrigerate after reconstitution.
Maintain sterile laboratory handling procedures at all times.
